Scienture Holdings, Inc. has entered into a securities purchase agreement with institutional investors to purchase 3,225,000 shares of common stock at $1.20 per share.
The gross proceeds for the offering are expected to be approximately $3.9 million before deducting fees and expenses.
The offering is expected to close on August 15, 2025.
Offering Details
3,225,000 shares of common stock at $1.20 per share.
Gross Proceeds
Expected to be approximately $3.9 million.
Closing Date
Expected on August 15, 2025.
Placement Agent
Maxim Group LLC is acting as the sole placement agent.
- The offering is being made through a registered direct offering with institutional investors.
- The gross proceeds from the offering will provide additional funding for Scienture Holdings, Inc.'s operations and growth plans.
This securities purchase agreement signifies an important milestone for Scienture Holdings, Inc. as it secures funding for its strategic initiatives and growth in the pharmaceutical sector.